Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $3.5692, but opened at $3.73. Raia Drogasil shares last traded at $3.73, with a volume of 300 shares.
Raia Drogasil Stock Performance
The business has a 50 day moving average of $3.57 and a 200 day moving average of $4.11.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, meeting the consensus estimate of $0.05. The company had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current year.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Palantir’s Kool-Aid Moment: The Math Behind Karp’s Forecast
- OpenAI’s Jalapeño Chip Could Change the AI Hardware Race
- Gold and Bitcoin Are Rebounding—2 ETFs Give Investors a Different Kind of Exposure
- HONA: The Spin-Off Story the Market Is Reading Wrong
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
